Telotristat ethyl is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in adults inadequately controlled by somatostatin analog therapy. As a prodrug, it is… Read more
Telotristat ethyl is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in adults inadequately controlled by somatostatin analog therapy. As a prodrug, it is metabolized into the active compound telotristat, which reduces peripheral serotonin production to alleviate the debilitating gastrointestinal symptoms associated with neuroendocrine tumors. This category provides essential reference standards, including the parent drug, its active metabolite, and associated impurities for comprehensive pharmaceutical analysis. Laboratories utilize these compounds for method validation, impurity profiling, and robust quality control procedures. Additionally, stable isotope labelled compounds, such as deuterated analogues, are vital in liquid chromatography-mass spectrometry applications, where they serve as precise internal standards to ensure quantitative accuracy and mitigate matrix effects during bioanalytical investigations. These materials are fundamental to maintaining regulatory compliance and ensuring data integrity throughout drug development and analytical research.